Induction chemoimmunotherapy

DRUG2 trials

Sponsors

Sun Yat-sen University, Shanghai Chest Hospital

Conditions

Esophageal Squamous Cell Carcinoma (ESCC)Locally Advanced Non-Small Cell Lung CancerNon-Small Cell Lung CancerUnresectable Stage III NSCLC

Phase 1

Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

Active, not recruitingNCT07632365

Shanghai Chest HospitalLocally Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Unresectable Stage III NSCLC

Start: 2022-10-09End: 2027-11-30Updated: 2026-06-08

Phase 2

Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma

RecruitingNCT06912074

Sun Yat-sen UniversityEsophageal Squamous Cell Carcinoma (ESCC)

Start: 2025-04-05End: 2029-04-04Target: 134Updated: 2025-11-17